Two types of ammonium uranyl nitrate (NH4)2UO2(NO3)4·2H2O and NH4UO2(NO3)3, were thermally decomposed and reduced in a TG-DTA unit in nitrogen, air, and hydrogen atmospheres. Various intermediate
phases produced by the thermal decomposition and reduction process were investigated by an X-ray diffraction analysis and
a TG/DTA analysis. Both (NH4)2UO2(NO3)4·2H2O and NH4UO2(NO3)3 decomposed to amorphous UO3 regardless of the atmosphere used. The amorphous UO3 from (NH4)2UO2(NO3)4·2H2O was crystallized to γ-UO3 regardless of the atmosphere used without a change in weight. The amorphous UO3 obtained from decomposition of NH4UO2(NO3)3 was crystallized to α-UO3 under a nitrogen and air atmosphere, and to β-UO3 under a hydrogen atmosphere without a change in weight. Under each atmosphere, the reaction paths of (NH4)2UO2(NO3)4·2H2O and NH4UO2(NO3)3 were as follows: under a nitrogen atmosphere: (NH4)2UO2(NO3)4·2H2O → (NH4)2UO2(NO3)4·H2O → (NH4)2UO2(NO3)4 → NH4UO2(NO3)3 → A-UO3 → γ-UO3 → U3O8, NH4UO2(NO3)3 → A-UO3 → α-UO3 → U3O8; under an air atmosphere: (NH4)2UO2(NO3)4·2H2O → (NH4)2UO2(NO3)4·H2O → (NH4)2UO2(NO3)4 → NH4UO2(NO3)3 → A-UO3 → γ-UO3 → U3O8, NH4UO2(NO3)3 → A-UO3 → α-UO3 → U3O8; and under a hydrogen atmosphere: (NH4)2UO2(NO3)4·2H2O → (NH4)2UO2(NO3)4·H2O → (NH4)2UO2(NO3)4 → NH4UO2(NO3)3 → A-UO3 → γ-UO3 → α-U3O8 → UO2, NH4 UO2(NO3)3 → A-UO3 → β-UO3 → α-U3O8 → UO2.
Authors:A. Kumar, R.K. Dubey, K. Kant, D. Sasmal, M. Ghosh, and N. Sharma
Deltamethrin, a well-known type 2 synthetic pyrethroid insecticide, is a widespread environmental toxicant. It has potential to accumulate in body fluids and tissues due to its lipophilic characteristics. The immune system is among the most sensitive targets regarding toxicity of environmental pollutants. Various methods are available in the literature to analyze deltamethrin (DLM) concentration in plasma and tissues, but regarding the immune organs, only one gas chromatography–tandem mass spectrometry (GC–MS/MS) method (on spleen tissues) has been reported. In the present investigation, a rapid and sensitive high-performance liquid chromatography (HPLC) method has been developed and validated to determine DLM concentration in plasma, thymus, and spleen using zaleplone as an internal standard. Liquid chromatography (LC) separation is performed on an Agilent Zorbax® C8 column (250 mm × 4.6 mm, i.d., 5 μm) with isocratic elution using a mobile phase consisting of acetonitrile–5 mM KH2PO4 (70:30, v/v) at a flow rate of 1 mL min−1. The lower limit of quantification (LLOQ) for DLM is 10 ng mL−1 (plasma, thymus, and spleen). The method has been validated in terms of establishing linearity, specificity, sensitivity, recovery, accuracy, and precision (intra- and inter-day) and stabilities study. This validated method was successfully applied to a pharmacokinetic and tissue distribution study of DLM in mice.